Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Carlyle Group to acquire pharma firm Vectura for $1.4bn
Private equity firm Carlyle Group’s subsidiary Murano Bidco has agreed to acquire British pharmaceutical company Vectura Group for about $1.4bn (£958m).
Drug Delivery
-
27 May 2021
-
13 May 2021
CD&R agrees to acquire UDG Healthcare for $3.7bn
Clayton, Dubilier & Rice (CD&R), a private investment firm, has signed an agreement to acquire London-listed UDG Healthcare for £2.6bn ($3.7bn).
-
16 Apr 2021
GSK and Vir announce EMA review of VIR-7831 for early treatment of Covid-19
GlaxoSmithKline and Vir Biotechnology have announced the European Medicines Agency (EMA) review of VIR-7831 (GSK4182136) for the early treatment of Covid-19.
-
17 Mar 2021
AstraZeneca to deliver 500,000 more doses of AZD7442 to US
The UK’s Cambridge-based biopharma company AstraZeneca will be delivering 500,000 more doses of AZD7442 to the US after having modified an existing agreement with the US Government.
-
10 Feb 2021
USFDA approves EUA for bamlanivimab-etesevimab combo to treat Covid-19 patients
The U.S. Food and Drug Administration (FDA) has approved Emergency Use Authorization (EUA) for investigational bamlanivimab and etesevimab as a combination therapy for the treatment of mild to moderate Covid-19 patients.
-
26 Dec 2018
Researchers conduct study to identify common genetic architecture of PCOS
International PCOS Consortium has carried out a study to determine the common genetic architecture for different diagnostic criteria that are employed to describe polycystic ovary syndrome (PCOS).